[
    [
        {
            "time": "",
            "original_text": "【浙商医药|周报】估值持续回落，重点推荐有望进入业绩加速期的CDMO",
            "features": {
                "keywords": [
                    "医药",
                    "估值回落",
                    "业绩加速",
                    "CDMO"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【浙商医药|周报】估值持续回落，重点推荐有望进入业绩加速期的CDMO",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]